Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/METX stock hub

CSE/METX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/METXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

88.6M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/METX

In the news

Latest news · CSE/METX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-82.5

P25 -121.5P50 -40.9P75 0.5

ROIC-54.6

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/METX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

133

Groups with data

Currency

CAD

Showing 133 of 133 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 87.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	CAD 88.6M
Price	CAD 2.95
Price currency	CAD
Sector	Healthcare
Sic	8049
Symbol	cse/METX
Website	https://www.metherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.51%
EV Earnings	-65.77x
EV/FCF	-69.71x
FCF yield	-1.42%
P/B ratio	84.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -1.3M
ROA	-52.06
Roa5y	-90.27
ROCE	-141.4
ROE	-82.48
ROIC	-54.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-68.97%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 1.2M
Cash	CAD 856,670
Current Assets	CAD 967,794
Current Liabilities	CAD 158,072
Debt	CAD 42,457
Debt Equity	CAD 0.04
Debt FCF	CAD -0.03
Equity	CAD 1M
Interest Coverage	-144.5
Liabilities	CAD 158,072
Long Term Assets	CAD 233,721
Long Term Liabilities	CAD 0
Net Cash	CAD 814,213
Net Cash By Market Cap	CAD 0.92
Net Cash Growth	-57.16%
Net Debt Equity	CAD -0.78
Tangible Book Value	CAD 1M
Tangible Book Value Per Share	CAD 0.03
WACC	4.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.12
Net Working Capital	CAD -4,491
Quick ratio	5.65
Working Capital	CAD 809,722

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-68.95%
200-day SMA	5.27
50-day SMA	3.94
50-day SMA vs 200-day SMA	50under200
All Time High	11
All Time High Change	-73.18%
All Time High Date	2025-03-19
All Time Low	0.05
All Time Low Change	5,800%
All Time Low Date	2023-11-29
ATR	0.57
Beta	0.12
Beta1y	2.68
Beta2y	2.93
Ch YTD	-26.25
High	2.95
High52	10.4
High52 Date	2025-05-13
High52ch	-71.63%
Low	2.95
Low52	2
Low52 Date	2026-02-13
Low52ch	47.5%
Ma50ch	-25.15%
Price vs 200-day SMA	-43.99%
RSI	47.31
RSI Monthly	47.44
RSI Weekly	43.33
Sharpe ratio	1.24x
Sortino ratio	2.52
Total Return	-16.39%
Tr YTD	-26.25
Tr1m	18%
Tr3m	18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -1.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,116,675%
Net Borrowing	-65,948
Shares Insiders	56.35%
Shares Out	30,049,494
Shares Qo Q	0.87%
Shares Yo Y	16.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -1.3M
Average Volume	649.6x
Bv Per Share	0.03
CAPEX	CAD -84,512
Ch1m	18
Ch1y	-68.95
Ch3m	18
Ch6m	-26.25
Change	0%
Change From Open	0
Close	2.95
Days Gap	0
Depreciation Amortization	26,778
Earnings Date	2026-05-12
EBIT	CAD -1.5M
EBITDA	CAD -1.4M
EPS	CAD -0.04
F Score	1
FCF	CAD -1.3M
FCF EV Yield	-1.43x
FCF Per Share	CAD -0.04
Financing CF	118,052
Fiscal Year End	August
Founded	2,014
Investing CF	-142,012
Is Primary Listing	1
Last Earnings Date	2025-11-27
Last Report Date	2026-02-28
Ma150	5.67
Ma150ch	-47.97%
Ma20	2.95
Ma20ch	0%
Net CF	-1,199,394
Next Earnings Date	2026-05-12
Open	2.95
Ppne	222,829
Price Date	2026-05-07
Ptbv Ratio	84.96
Relative Volume	0.15x
Tr6m	-26.25%
Volume	0

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/METX pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/METX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/METX?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+56.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+16.4%

Negative means the company is buying back shares.

Technical

CSE/METX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

-44.0%

50/200-day relationship not available

Beta (5Y)

0.12

Less volatile than the market

Sharpe ratio

1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/METX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/METX stock rating?

cse/METX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/METX analysis?

The full report lives at /stocks/cse/METX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/METX?

The latest report frames cse/METX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/METX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.